- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Apotea AB (APOTEA)
Apotea AB stock price live, this page displays ST APOTEA stock exchange data. View the APOTEA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Apotea AB real time stock price chart below.
What Is the Apotea AB Stock Price Today?
The Apotea AB stock price today is 82.05.
What Is the Stock Symbol for Apotea AB?
The stock symbol for Apotea AB is "APOTEA."
What Stock Exchange Does Apotea AB Trade On?
Apotea AB is listed and trades on the Stockholm stock exchange.
Is Apotea AB a Good Stock to Buy?
Determining whether Apotea AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the APOTEA quote. (ISIN: SE0023313762)
What Is the Apotea AB Stock Price Today?
The Apotea AB stock price today is 82.05.
What Is the Stock Symbol for Apotea AB?
The stock symbol for Apotea AB is "APOTEA."
What Stock Exchange Does Apotea AB Trade On?
Apotea AB is listed and trades on the Stockholm stock exchange.
Is Apotea AB a Good Stock to Buy?
Determining whether Apotea AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the APOTEA quote. (ISIN: SE0023313762)
82.05
-1.05(-1.26%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
81.85
83.75
52 wk Range
54.42
94.70
APOTEA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
81.8583.75
52 wk Range
54.4294.70
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.72%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.72%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
APOTEA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
92.50
Upside
+12.74%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Cash flows can sufficiently cover interest payments
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 92.50
(+12.74% Upside)
Apotea AB Earnings Call Summary for Q2/2026
- Apotea Q2 revenue rose 10.9% YoY to SEK 2,026M, topping forecast; adjusted EBIT margin held steady at 5.2%, shares surged 8.21% in pre-market.
- New Varberg fulfillment center now processes 30,000+ daily orders; inventory climbed to SEK 850M, pressuring cash flow amid operational ramp-up.
- Company launched apotea.no in Norway with gradual marketing rollout; management eyes long-term expansion in new market despite early-stage uncertainty.
- CEO Svärdson projects 'single-digit %' quarterly growth improvements; annual capex expected at SEK 50-70M as firm optimizes fulfillment operations.
- Rolling 12-month revenue neared SEK 7.6B with 4.2% adjusted EBIT margin; analysts note stock trades 34.7% below 52-week high, citing upside potential.
Last Updated: 2026-07-17, 04:02 a/m
Read Full TranscriptEarnings
Latest Release
Jul 17, 2026
EPS / Forecast
0.78 / 0.71
Revenue / Forecast
2.03B / 2.01B
Compare APOTEA to Peers and Sector
Metrics to compare | APOTEA | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship RelationshipAPOTEAPeersSector | |
|---|---|---|---|---|
P/E Ratio | 34.8x | 10.8x | 10.9x | |
PEG Ratio | −19.81 | 0.05 | 0.03 | |
Price/Book | 9.0x | 1.6x | 1.5x | |
Price / LTM Sales | 1.1x | 1.7x | 0.9x | |
Upside (Analyst Target) | 12.7% | −1.6% | 28.5% | |
Fair Value Upside | Unlock | 11.4% | 14.3% | Unlock |
Apotea AB (publ) operates an online pharmacy in Sweden. The company offers products in the areas of allergy, face, baby, child and parent, bite and sting, preparedness, animal, fever and aches, cold, home and household, aid, hair removal and shaving, hair care, hands and feet, intimate, and dietary supplements. It also provides products in the categories of body care, stomach and intestine, food and drink, mouth and teeth, premium, trip, sex and lust, stop smoking, makeup, sun protection, wounds and injuries, sleep and sleep problems, training, weight control, vitamins and minerals, charity, and eyes and ears. In addition, the company offers leasing and hiring out personnel to related companies, as well as marketing contributions. The company was founded in 2011 and is headquartered in Stockholm, Sweden.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Apotea (APOTEA) Stock Price Today?
The Apotea stock price today is 82.05 SEK.
What Stock Exchange Does Apotea Trade On?
Apotea is listed and trades on the Stockholm Stock Exchange.
What Is the Stock Symbol for Apotea?
The stock symbol for Apotea is "APOTEA."
Does Apotea Pay Dividends? What’s The Current Dividend Yield?
The Apotea dividend yield is 0.72%.
What Is the Apotea Market Cap?
As of today, Apotea market cap is 8.54B SEK.
What Is Apotea's Earnings Per Share (TTM)?
The Apotea EPS (TTM) is 2.36.
When Is the Next Apotea Earnings Date?
Apotea will release its next earnings report on Nov 05, 2026.
From a Technical Analysis Perspective, Is APOTEA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Apotea Stock Split?
Apotea has split 0 times.
How Many Employees Does Apotea Have?
Apotea has 736 employees.
What is the current trading status of Apotea (APOTEA)?
As of Oct 03, 2026, Apotea (APOTEA) is trading at a price of 82.05 SEK, with a previous close of 83.10 SEK. The stock has fluctuated within a day range of 81.85 SEK to 83.75 SEK, while its 52-week range spans from 54.42 SEK to 94.70 SEK.
What Is Apotea (APOTEA) Price Target According to Analysts?
The average 12-month price target for Apotea is 92.50 SEK, with a high estimate of 100 SEK and a low estimate of 85 SEK. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +12.74% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.